Keywords
MedicineAtrial fibrillationAspirinAntithromboticWarfarinStroke (engine)ThrombosisIntensive care medicineAnticoagulantClinical trialAnticoagulant therapyCardiologyInternal medicine
Affiliated Institutions
Related Publications
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Adjusted-dose warfarin and antiplatelet agents reduce stroke by approximately 60% and by approximately 20%, respectively, in patients who have atrial fibrillation. Warfarin is s...
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
The aim of this updated guideline is to provide comprehensive and timely evidence-based recommendations on the prevention of future stroke among survivors of ischemic stroke or ...
Selecting Patients With Atrial Fibrillation for Anticoagulation
Background— The rate of stroke in atrial fibrillation (AF) depends on the presence of comorbid conditions and the use of antithrombotic therapy. Although adjusted-dose warfarin ...
Publication Info
- Year
- 2007
- Type
- review
- Volume
- 6
- Issue
- 11
- Pages
- 981-993
- Citations
- 235
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
235
OpenAlex
Cite This
Gregory Y.H. Lip,
Hoong Sern Lim
(2007).
Atrial fibrillation and stroke prevention.
The Lancet Neurology
, 6
(11)
, 981-993.
https://doi.org/10.1016/s1474-4422(07)70264-8
Identifiers
- DOI
- 10.1016/s1474-4422(07)70264-8